USPTO Grants Patent for Therapeutic Gas Delivery Cart
Summary
The USPTO has granted a design patent (USD1120338S1) for a therapeutic gas delivery cart to Mallinckrodt Pharmaceuticals Ireland Limited. The patent, which covers the design of the cart, was granted on March 24, 2026, with a filing date of June 17, 2025.
What changed
The United States Patent and Trademark Office (USPTO) has issued a design patent, USD1120338S1, for a therapeutic gas delivery cart. The patent was granted to Mallinckrodt Pharmaceuticals Ireland Limited, with inventors Brian McCormack, Michael McAtamney, and Jaron Matthew Acker. This patent specifically covers the ornamental design of the cart, not its functional aspects or efficacy, and is classified under CPC codes related to medical devices and gas delivery systems.
This patent grant signifies the protection of the unique visual appearance of the therapeutic gas delivery cart. While it does not impose new regulatory obligations on other manufacturers or healthcare providers, it establishes intellectual property rights for Mallinckrodt Pharmaceuticals. Companies developing or manufacturing similar gas delivery carts should be aware of this patent to avoid potential infringement claims and ensure their designs do not mimic the protected ornamental features.
What to do next
- Review patent details for potential design overlap if manufacturing similar devices.
Source document (simplified)
Therapeutic gas delivery cart
Design USD1120338S1 Kind: S1 Mar 24, 2026
Assignee
Mallinckrodt Pharmaceuticals Ireland Limited
Inventors
Brian McCormack, Michael McAtamney, Jaron Matthew Acker
CPC Classifications
A61F 9/007 A61F 9/00745 A61F 9/008 A61B 50/13 A61B 50/10 A61B 5/742
Filing Date
2025-06-17
Application No.
30008765
Claims
1
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: Patent Grants - Prosthetics (A61F) publishes new changes.